Page 55 - Portuguese Journal - SPORL - Vol 54 Nº3

indications for elective treatment of the neck in cancer of the major
salivary glands. 1992; Cancer 69:615.
8.Zbaren P, Schupbach J, Nuyens M, Stauffer E. Elective neck dissection
versus observation in primary parotid carcinoma. Otolaryngol Head
Neck Surg. 2005; 132:387.
9.Kelley DJ, Spiro RH. Management of the neck in parotid carcinoma.
Am J Surg 1996; 172:695–7.
10.Nobis CP, Rohleder NH, Wolff KD, Wagenpfeil S et al. Head and neck
salivary gland carcinomas - elective neck dissection, yes or no? J Oral
Maxillofac Surg. 2014; 72(1):205-10.
11.Al-Mamgani A, Van Rooij P, Verduijn GM, Meeuwis CA et al. Long-
term outcomes and quality of life of 186 patients with primary parotid
carcinoma treated with surgery and radiotherapy at the Daniel den
Hoed Cancer Center. Int J Radiat Oncol Biol Phys. 2012; 84(1):189-95.
12.Pohar S, Gay H, Rosenbaum P, Klish D et al. Malignant parotid
tumors: Presentation, clinical/pathological prognostic factors, and
treatment outcomes. Int J Radiat Oncol Biol Phys 2005; 61:112-118.
13.Terhaard CHJ, Lubsen H, Rasch CRN, Levendag PC et al. The role of
radiotherapy in the treatment of malignant salivary gland tumors. Int
J Radiat Oncol Biol Phys 2005; 61:103-111.
14.Richter SM, Friedmann P, Mourad WF, Hu KS et al. Postoperative CASO CLÍNICO CASE REPORT
radiation therapy for small, low-/intermediate-grade parotid tumors
with close and/or positive surgical margins. Head Neck 2012;
34(7):953-5.
15.Stodulski D, Mikaszewski B, Stankiewicz C. Are all prognostic factors
in parotid gland carcinoma well recognized? Eur Arch Otorhinolaryngol
2012; 269(3): 1019–1025.
16.Ghosh-Laskar S, Murthy V, Wadasadawala T, Agarwal J.
Mucoepidermoid carcinoma of the parotid gland: factors affecting
outcome. Head Neck 2011; 33(4):497-503.
17.Armstrong JG, Harrison LB, Spiro RH, Fass DE et al. Malignant
tumors of major salivary gland origin. Arch Otolaryngol Head Neck
Surg 1990; 116:290–293.
18.Terhaard CHJ, Lubsen H, Rasch CRN, Levendag PC et al. The role of
radiotherapy in the treatment of malignant salivary gland tumors. Int
J Radiat Oncol Biol Phys 2005; 61:103–111.
19.Terhaard CHJ, Lubsen H, Van Der Tweel, Hilgers FJ et al. Salivary
gland carcinoma: independent prognostic factors for locoregional
control, distant metastases, and overall survival: results of the Dutch
Head and Neck Oncology Cooperative Group. Head Neck 2004;
26:681–693.
20.Therkildsen MH, Christensen M, Andersen LJ, Schiødt T et al.
Salivary gland carcinomas-prognostic factors. Acta Oncol 1998;
37:701–713.
21.Fu KK, Leibel SA, Levine ML, Friedlander LM et al. Carcinoma of
the major and minor salivary glands. Analysis of treatment results and
sites and causes of failures. Cancer 1977; 40 (6): 2882-2890.
22.Poulsen MG, Pratt GR, Kynaston B, Tripcony LB. Prognostic variables
in malignant epithelial tumors of the parotid. Int J Radiat Oncol Biol
Phys 1992; 23:327–330.
23.Mendenhall WM, Morris CG, Amdur RJ, Werning JW et al.
Radiotherapy alone or combined with surgery for salivary gland
carcinoma. Cancer 2005; 103:2544–2550.
24.Chen WC, Liao CT, Tsai HC, Yeh JY et al. Radiation-induced hearing
impairment in patients treated for malignant parotid tumor. Ann Otol
Rhinol Laryngol 1999; 108(12):1159-1164.

VOL 54 . Nº3 . SETEMBRO 2016 197